Verified peer comparison
Scribe Therapeutics vs TransAct Technologies Financial Comparison
Direct answer
Scribe Therapeutics and TransAct Technologies are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Scribe Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Scribe Therapeutics Revenue
- 51,174,000 USD
- TransAct Technologies Revenue
- 51,480,000 USD
- Scribe Therapeutics Operating income
- -26,070,000 USD
- TransAct Technologies Operating income
- -1,415,000 USD